Literature DB >> 7751703

Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells.

Y Shemer-Avni1, D Lieberman.   

Abstract

The ciliary activity of ciliated bronchial epithelial cells was studied after infection with Chlamydia pneumoniae (strain TW-183) and Chlamydia trachomatis (biovar L2 [434/Bu]). C. pneumoniae, known to cause respiratory infections, had a marked ciliastatic effect, completely aborting ciliary motion within 48 h. This effect was not inhibited by inactivation of C. pneumoniae elementary bodies (EBs) by UV irradiation. In contrast, inactivation of EBs by heat (56 degrees C, 30 min) or by rabbit-specific immune sera to TW-183 antigen blocked the ciliastatic effect induced by C. pneumoniae infection. The effect of C. pneumoniae was specific. C. trachomatis, which causes sexually transmitted disease, did not block ciliary motion by 48 h after infection. A decrease in ciliary activity of ciliated bronchial cells produced by C. pneumoniae can contribute to both initiation and pathogenesis of respiratory infections induced by this pathogen.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7751703     DOI: 10.1093/infdis/171.5.1274

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  The Role of Chlamydia in Upper Respiratory Tract Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-04       Impact factor: 3.725

2.  Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia.

Authors:  R Chaudhry; N Nazima; B Dhawan; S K Kabra
Journal:  Indian J Pediatr       Date:  1998 Sep-Oct       Impact factor: 1.967

3.  Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

Authors:  D Lieberman; M Ben-Yaakov; Z Lazarovich; A Porath; F Schlaeffer; D Lieberman; M Leinonen; P Saikku; O Horovitz; I Boldur
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

4.  Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines.

Authors:  W S Lim; J T Macfarlane; T C Boswell; T G Harrison; D Rose; M Leinonen; P Saikku
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

5.  Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients.

Authors:  D Lieberman; F Schlaeffer; I Boldur; D Lieberman; S Horowitz; M G Friedman; M Leiononen; O Horovitz; E Manor; A Porath
Journal:  Thorax       Date:  1996-02       Impact factor: 9.139

6.  Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation.

Authors:  Shuang Chen; Rosalinda Sorrentino; Kenichi Shimada; Yonca Bulut; Terence M Doherty; Timothy R Crother; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment.

Authors:  F Blasi; S Damato; R Cosentini; P Tarsia; R Raccanelli; S Centanni; L Allegra
Journal:  Thorax       Date:  2002-08       Impact factor: 9.139

8.  Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity.

Authors:  David L Hahn; Allison Schure; Katir Patel; Tawanna Childs; Eduard Drizik; Wilmore Webley
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

9.  Immunopathogenesis of Chlamydia pneumoniae Infections in children.

Authors:  M R Hammerschlag
Journal:  Infect Dis Obstet Gynecol       Date:  1996

10.  Causative agent distribution and antibiotic therapy assessment among adult patients with community acquired pneumonia in Chinese urban population.

Authors:  Youning Liu; Minjun Chen; Tiemei Zhao; Hui Wang; Rui Wang; Baiqiang Cai; Bin Cao; Tieying Sun; Yunjian Hu; Qingyu Xiu; Xin Zhou; Xing Ding; Lan Yang; Jiansheng Zhuo; Yingchun Tang; Kouxing Zhang; Derong Liang; Xiaoju Lv; Shengqi Li; Yong Liu; Yunsong Yu; Zeqing Wei; Kejing Ying; Feng Zhao; Ping Chen; Xiaona Hou
Journal:  BMC Infect Dis       Date:  2009-03-18       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.